Mbx Biosciences Inc (MBX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 49,351 | 30,523 | 24,210 |
| Marketable Securities | 212,798 | 50,153 | 18,251 |
| TOTAL | $267,286 | $83,465 | $44,211 |
| Non-Current Assets | |||
| PPE Net | 1,080 | 439 | 521 |
| Other Non-Current Assets | 169 | 276 | 363 |
| TOTAL | $1,249 | $715 | $884 |
| Total Assets | $268,535 | $84,180 | $45,095 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 5,335 | 1,391 | 976 |
| Accrued Expenses | 5,545 | 2,382 | 2,318 |
| TOTAL | $11,051 | $3,926 | $3,431 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 42 | 152,722 | 84,269 |
| TOTAL | $42 | $152,722 | $84,269 |
| Total Liabilities | $11,093 | $156,648 | $87,700 |
| Shareholders' Equity | |||
| Shares Outstanding, K | 33,424 | N/A | N/A |
| Common Shares | 5 | 1 | 1 |
| Retained earnings | -137,505 | -75,583 | -43,020 |
| Other shareholders' equity | 55 | 60 | 3 |
| TOTAL | $257,442 | $-72,468 | $-42,605 |
| Total Liabilities And Equity | $268,535 | $84,180 | $45,095 |